☆ 4.7 Article

Study of erdafitinib stress degradation behavior using HPLC-UV analysis and multistage fragmentation ion trap mass spectrometry

MICROCHEMICAL JOURNAL (2022)

HPLC-UV determination of erdafitinib in mouse plasma and its application to pharmacokinetic studies

Tarek Elawady et al.

Summary: Erdafitinib is a recently approved FGFR inhibitor for patients with metastatic bladder cancer. A validated HPLC-UV method was developed for the determination of erdafitinib in mouse plasma. The method was successfully applied to pharmacokinetic studies of the drug.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2021)

添加到收藏夹

Article Chemistry, Analytical

LC-MS/MS determination of erdafitinib in human plasma after SPE: Investigation of the method greenness

Tarek Elawady et al.

MICROCHEMICAL JOURNAL (2020)

添加到收藏夹

Review Cell Biology

Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors

Shuyan Dai et al.

CELLS (2019)

添加到收藏夹

Review Oncology

Targeting FGFR Signaling in Cancer

Mehdi Touat et al.

CLINICAL CANCER RESEARCH (2015)

添加到收藏夹

Study of erdafitinib stress degradation behavior using HPLC-UV analysis and multistage fragmentation ion trap mass spectrometry

相关参考文献

HPLC-UV determination of erdafitinib in mouse plasma and its application to pharmacokinetic studies

LC-MS/MS determination of erdafitinib in human plasma after SPE: Investigation of the method greenness

Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors

Targeting FGFR Signaling in Cancer

导出引文

分享论文